_id
69185e343c536f8df2317d7c
Ticker
0QYQ.LSE
Name
Gilead Sciences Inc.
Exchange
LSE
Address
333 Lakeside Drive, Foster City, CA, United States, 94404
Country
UK
Sector
Industry
Currency
USD
Website
https://www.gilead.com
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.
Last Close
61.06
Volume
2207
Current Price
117.82
Change
0
Last Updated
2025-12-05T15:05:23.340Z
Image
https://logo.clearbit.com/www.gilead.com
Ipo Date
-
Market Cap
80155110000
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2023-06-30
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
-
Operating Income
-
Interest Expense
-
Pretax Income
-
Net Income
-
Eps
-
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
549000000
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-
Cash
-
Short Term Investments
-
Receivables
4229000000
Inventories
3181000000
Total Current Assets
15411000000
Property Plant Equipment
5540000000
Total Assets
-
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
13964000000
Equity
-
Depreciation
-
Change In Working Capital
-
Cash From Operations
2337000000
Capital Expenditures
0
Cash From Investing
-483000000
Cash From Financing
-1101000000
Net Change In Cash
768000000
PE
-
PB
-
ROE
-
ROA
-
FCF
2337000000
Fcf Percent
-
Piotroski FScore
1
Health Score
46
Deep Value Investing Score
0.5
Defensive Investing Score
3
Dividend Investing Score
1.5
Economic Moat Investing Score
1.5
Garp Investing Score
0
Growth Investing Score
0
Momentum Investing Score
2.5
Net Net Investing Score
0
Quality Investing Score
0.5
Value Investing Score
0.5
Quarters > 0 > quarter
2023-06-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
-
Quarters > 0 > income Statement > operating Income
-
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-
Quarters > 0 > income Statement > net Income
-
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
-
Quarters > 0 > income Statement > income Tax Expense
549000000
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > balance Sheet > cash
-
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
4229000000
Quarters > 0 > balance Sheet > inventories
3181000000
Quarters > 0 > balance Sheet > total Current Assets
15411000000
Quarters > 0 > balance Sheet > property Plant Equipment
5540000000
Quarters > 0 > balance Sheet > total Assets
-
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
13964000000
Quarters > 0 > balance Sheet > equity
-
Quarters > 0 > cash Flow > net Income
1045000000
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
2337000000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-483000000
Quarters > 0 > cash Flow > cash From Financing
-1101000000
Quarters > 0 > cash Flow > net Change In Cash
768000000
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
-
Quarters > 0 > ratios > ROA
-
Quarters > 0 > ratios > FCF
2337000000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
46
Quarters > 1 > quarter
2023-03-31
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
-
Quarters > 1 > income Statement > operating Income
-
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-
Quarters > 1 > income Statement > net Income
-
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > balance Sheet > cash
-
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
-
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
-
Quarters > 1 > balance Sheet > payables
-
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
10528000000
Quarters > 1 > balance Sheet > equity
-
Quarters > 1 > cash Flow > net Income
1010000000
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
2337000000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-826000000
Quarters > 1 > cash Flow > cash From Financing
-1101000000
Quarters > 1 > cash Flow > net Change In Cash
768000000
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-
Quarters > 1 > ratios > ROA
-
Quarters > 1 > ratios > FCF
2337000000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
46
Quarters > 2 > quarter
2022-12-31
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
-
Quarters > 2 > income Statement > operating Income
-
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-
Quarters > 2 > income Statement > net Income
-
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
915000000
Quarters > 2 > income Statement > shares Outstanding
-
Quarters > 2 > income Statement > income Tax Expense
398000000
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > balance Sheet > cash
-
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
4777000000
Quarters > 2 > balance Sheet > inventories
1507000000
Quarters > 2 > balance Sheet > total Current Assets
14443000000
Quarters > 2 > balance Sheet > property Plant Equipment
5980000000
Quarters > 2 > balance Sheet > total Assets
-
Quarters > 2 > balance Sheet > payables
905000000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
11237000000
Quarters > 2 > balance Sheet > equity
-
Quarters > 2 > cash Flow > net Income
1640000000
Quarters > 2 > cash Flow > depreciation
528000000
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
2567000000
Quarters > 2 > cash Flow > capital Expenditures
181000000
Quarters > 2 > cash Flow > cash From Investing
-375000000
Quarters > 2 > cash Flow > cash From Financing
-1554000000
Quarters > 2 > cash Flow > net Change In Cash
713000000
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-
Quarters > 2 > ratios > ROA
-
Quarters > 2 > ratios > FCF
2386000000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
46
Quarters > 3 > quarter
2022-09-30
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
-
Quarters > 3 > income Statement > operating Income
-
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-
Quarters > 3 > income Statement > net Income
-
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
929000000
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
646000000
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > balance Sheet > cash
-
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
4354000000
Quarters > 3 > balance Sheet > inventories
1463000000
Quarters > 3 > balance Sheet > total Current Assets
13554000000
Quarters > 3 > balance Sheet > property Plant Equipment
5349000000
Quarters > 3 > balance Sheet > total Assets
-
Quarters > 3 > balance Sheet > payables
614000000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
10423000000
Quarters > 3 > balance Sheet > equity
-
Quarters > 3 > cash Flow > net Income
1789000000
Quarters > 3 > cash Flow > depreciation
525000000
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
2863000000
Quarters > 3 > cash Flow > capital Expenditures
157000000
Quarters > 3 > cash Flow > cash From Investing
-713000000
Quarters > 3 > cash Flow > cash From Financing
-2118000000
Quarters > 3 > cash Flow > net Change In Cash
-40000000
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
-
Quarters > 3 > ratios > ROA
-
Quarters > 3 > ratios > FCF
2706000000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
46
Annuals > 0 > quarter
2022-12-31
Annuals > 0 > income Statement > revenue
-
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
-
Annuals > 0 > income Statement > operating Income
-
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-
Annuals > 0 > income Statement > net Income
-
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
3709000000
Annuals > 0 > income Statement > shares Outstanding
-
Annuals > 0 > income Statement > income Tax Expense
1248000000
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > balance Sheet > cash
-
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
4777000000
Annuals > 0 > balance Sheet > inventories
1507000000
Annuals > 0 > balance Sheet > total Current Assets
14443000000
Annuals > 0 > balance Sheet > property Plant Equipment
5980000000
Annuals > 0 > balance Sheet > total Assets
-
Annuals > 0 > balance Sheet > payables
905000000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
11237000000
Annuals > 0 > balance Sheet > equity
-
Annuals > 0 > cash Flow > net Income
4592000000
Annuals > 0 > cash Flow > depreciation
2103000000
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
9072000000
Annuals > 0 > cash Flow > capital Expenditures
728000000
Annuals > 0 > cash Flow > cash From Investing
-2466000000
Annuals > 0 > cash Flow > cash From Financing
-6469000000
Annuals > 0 > cash Flow > net Change In Cash
74000000
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
-
Annuals > 0 > ratios > ROA
-
Annuals > 0 > ratios > FCF
8344000000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
46
Annuals > 1 > quarter
2021-12-31
Annuals > 1 > income Statement > revenue
27305000000
Annuals > 1 > income Statement > cost Of Revenue
6601000000
Annuals > 1 > income Statement > gross Profit
20704000000
Annuals > 1 > income Statement > operating Expenses
-
Annuals > 1 > income Statement > operating Income
9918000000
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
8278000000
Annuals > 1 > income Statement > net Income
6225000000
Annuals > 1 > income Statement > eps
-
Annuals > 1 > income Statement > dividends Per Share
3605000000
Annuals > 1 > income Statement > shares Outstanding
-
Annuals > 1 > income Statement > income Tax Expense
2077000000
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
36.3230177623146
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > balance Sheet > cash
7829000000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
4493000000
Annuals > 1 > balance Sheet > inventories
1618000000
Annuals > 1 > balance Sheet > total Current Assets
14772000000
Annuals > 1 > balance Sheet > property Plant Equipment
5663000000
Annuals > 1 > balance Sheet > total Assets
67952000000
Annuals > 1 > balance Sheet > payables
705000000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
46888000000
Annuals > 1 > balance Sheet > equity
21064000000
Annuals > 1 > cash Flow > net Income
6225000000
Annuals > 1 > cash Flow > depreciation
2050000000
Annuals > 1 > cash Flow > change In Working Capital
11384000000
Annuals > 1 > cash Flow > cash From Operations
11384000000
Annuals > 1 > cash Flow > capital Expenditures
579000000
Annuals > 1 > cash Flow > cash From Investing
-3131000000
Annuals > 1 > cash Flow > cash From Financing
-8877000000
Annuals > 1 > cash Flow > net Change In Cash
-659000000
Annuals > 1 > ratios > PE
-
Annuals > 1 > ratios > PB
-
Annuals > 1 > ratios > ROE
29.552791492594
Annuals > 1 > ratios > ROA
9.16087826701201
Annuals > 1 > ratios > FCF
10805000000
Annuals > 1 > ratios > Piotroski FScore
3
Annuals > 1 > ratios > fcf Percent
0.39571507049990845
Annuals > 1 > health Score
66
Annuals > 2 > quarter
2020-12-31
Annuals > 2 > income Statement > revenue
24689000000
Annuals > 2 > income Statement > cost Of Revenue
4572000000
Annuals > 2 > income Statement > gross Profit
20117000000
Annuals > 2 > income Statement > operating Expenses
-
Annuals > 2 > income Statement > operating Income
4071000000
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
1669000000
Annuals > 2 > income Statement > net Income
123000000
Annuals > 2 > income Statement > eps
-
Annuals > 2 > income Statement > dividends Per Share
3449000000
Annuals > 2 > income Statement > shares Outstanding
-
Annuals > 2 > income Statement > income Tax Expense
1580000000
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
16.48912471140994
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > balance Sheet > cash
5997000000
Annuals > 2 > balance Sheet > short Term Investments
1411000000
Annuals > 2 > balance Sheet > receivables
4892000000
Annuals > 2 > balance Sheet > inventories
1683000000
Annuals > 2 > balance Sheet > total Current Assets
15996000000
Annuals > 2 > balance Sheet > property Plant Equipment
5613000000
Annuals > 2 > balance Sheet > total Assets
68407000000
Annuals > 2 > balance Sheet > payables
844000000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
28645000000
Annuals > 2 > balance Sheet > total Liabilities
50205000000
Annuals > 2 > balance Sheet > equity
18202000000
Annuals > 2 > cash Flow > net Income
123000000
Annuals > 2 > cash Flow > depreciation
1480000000
Annuals > 2 > cash Flow > change In Working Capital
-1638000000
Annuals > 2 > cash Flow > cash From Operations
8168000000
Annuals > 2 > cash Flow > capital Expenditures
650000000
Annuals > 2 > cash Flow > cash From Investing
-14615000000
Annuals > 2 > cash Flow > cash From Financing
770000000
Annuals > 2 > cash Flow > net Change In Cash
-5634000000
Annuals > 2 > ratios > PE
-
Annuals > 2 > ratios > PB
-
Annuals > 2 > ratios > ROE
0.6757499175914734
Annuals > 2 > ratios > ROA
0.17980616018828482
Annuals > 2 > ratios > FCF
7518000000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.3045080805216898
Annuals > 2 > health Score
44
Annuals > 3 > quarter
2019-12-31
Annuals > 3 > income Statement > revenue
22449000000
Annuals > 3 > income Statement > cost Of Revenue
4675000000
Annuals > 3 > income Statement > gross Profit
17774000000
Annuals > 3 > income Statement > operating Expenses
-
Annuals > 3 > income Statement > operating Income
4287000000
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
5160000000
Annuals > 3 > income Statement > net Income
5386000000
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
3222000000
Annuals > 3 > income Statement > shares Outstanding
-
Annuals > 3 > income Statement > income Tax Expense
-204000000
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
19.096619003073634
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > balance Sheet > cash
11631000000
Annuals > 3 > balance Sheet > short Term Investments
12721000000
Annuals > 3 > balance Sheet > receivables
3619000000
Annuals > 3 > balance Sheet > inventories
922000000
Annuals > 3 > balance Sheet > total Current Assets
30296000000
Annuals > 3 > balance Sheet > property Plant Equipment
5170000000
Annuals > 3 > balance Sheet > total Assets
61627000000
Annuals > 3 > balance Sheet > payables
713000000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
22094000000
Annuals > 3 > balance Sheet > total Liabilities
39102000000
Annuals > 3 > balance Sheet > equity
22525000000
Annuals > 3 > cash Flow > net Income
5386000000
Annuals > 3 > cash Flow > depreciation
1404000000
Annuals > 3 > cash Flow > change In Working Capital
-798000000
Annuals > 3 > cash Flow > cash From Operations
9144000000
Annuals > 3 > cash Flow > capital Expenditures
825000000
Annuals > 3 > cash Flow > cash From Investing
-7817000000
Annuals > 3 > cash Flow > cash From Financing
-7634000000
Annuals > 3 > cash Flow > net Change In Cash
-6309000000
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
-
Annuals > 3 > ratios > ROE
23.911209766925637
Annuals > 3 > ratios > ROA
8.739675791455044
Annuals > 3 > ratios > FCF
8319000000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.3705732994788187
Annuals > 3 > health Score
71
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > final Score
50
Profitability > verdict
Weak
Risk > final Score
50
Risk > verdict
High
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
50
Prev Profitabilities > 1
50
Prev Profitabilities > 2
50
Prev Risks > 0
50
Prev Risks > 1
50
Prev Risks > 2
50
Prev Liquidities > 0
50
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:58:00.293Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-10
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
1.88
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-10-30
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
2.47
Earnings History > 1 > eps Estimate
2.14
Earnings History > 1 > eps Difference
0.33
Earnings History > 1 > surprise Percent
15.4206
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-07
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
1.5618
Earnings History > 2 > eps Estimate
1.96
Earnings History > 2 > eps Difference
-0.3982
Earnings History > 2 > surprise Percent
-20.3163
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-08
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
1.0445
Earnings History > 3 > eps Estimate
1.77
Earnings History > 3 > eps Difference
-0.7255
Earnings History > 3 > surprise Percent
-40.9887
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-04
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
1.4162
Earnings History > 4 > eps Estimate
1.71
Earnings History > 4 > eps Difference
-0.2938
Earnings History > 4 > surprise Percent
-17.1813
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-06
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
0.9992
Earnings History > 5 > eps Estimate
1.53
Earnings History > 5 > eps Difference
-0.5308
Earnings History > 5 > surprise Percent
-34.6928
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-08
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
1.2902
Earnings History > 6 > eps Estimate
1.61
Earnings History > 6 > eps Difference
-0.3198
Earnings History > 6 > surprise Percent
-19.8634
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-04-25
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-3.344
Earnings History > 7 > eps Estimate
-1.32
Earnings History > 7 > eps Difference
-2.024
Earnings History > 7 > surprise Percent
-153.3333
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-13
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
1.1377
Earnings History > 8 > eps Estimate
1.72
Earnings History > 8 > eps Difference
-0.5823
Earnings History > 8 > surprise Percent
-33.8547
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-07
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
1.7343
Earnings History > 9 > eps Estimate
2.29
Earnings History > 9 > eps Difference
-0.5557
Earnings History > 9 > surprise Percent
-24.2664
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-03
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
0.8307
Earnings History > 10 > eps Estimate
1.34
Earnings History > 10 > eps Difference
-0.5093
Earnings History > 10 > surprise Percent
-38.0075
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-04-27
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0.801
Earnings History > 11 > eps Estimate
1.37
Earnings History > 11 > eps Difference
-0.569
Earnings History > 11 > surprise Percent
-41.5328
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-02-02
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
1.2975
Earnings History > 12 > eps Estimate
1.67
Earnings History > 12 > eps Difference
-0.3725
Earnings History > 12 > surprise Percent
-22.3054
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-10-27
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
1.4187
Earnings History > 13 > eps Estimate
1.9
Earnings History > 13 > eps Difference
-0.4813
Earnings History > 13 > surprise Percent
-25.3316
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-02
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
0.9079
Earnings History > 14 > eps Estimate
1.58
Earnings History > 14 > eps Difference
-0.6721
Earnings History > 14 > surprise Percent
-42.538
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-04-28
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
0.0151
Earnings History > 15 > eps Estimate
2.12
Earnings History > 15 > eps Difference
-2.1049
Earnings History > 15 > surprise Percent
-99.2877
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-02-01
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
0.3027
Earnings History > 16 > eps Estimate
0.69
Earnings History > 16 > eps Difference
-0.3873
Earnings History > 16 > surprise Percent
-56.1304
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-10-28
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
2.0539
Earnings History > 17 > eps Estimate
2.65
Earnings History > 17 > eps Difference
-0.5961
Earnings History > 17 > surprise Percent
-22.4943
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-07-29
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
1.2079
Earnings History > 18 > eps Estimate
1.87
Earnings History > 18 > eps Difference
-0.6621
Earnings History > 18 > surprise Percent
-35.4064
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-04-29
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
1.37
Earnings History > 19 > eps Estimate
2.08
Earnings History > 19 > eps Difference
-0.71
Earnings History > 19 > surprise Percent
-34.1346
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-02-04
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
1.2319
Earnings History > 20 > eps Estimate
2.19
Earnings History > 20 > eps Difference
-0.9581
Earnings History > 20 > surprise Percent
-43.7489
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-10-28
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
0.2855
Earnings History > 21 > eps Estimate
2.11
Earnings History > 21 > eps Difference
-1.8245
Earnings History > 21 > surprise Percent
-86.4692
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-07-30
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-2.6606
Earnings History > 22 > eps Estimate
1.11
Earnings History > 22 > eps Difference
-3.7706
Earnings History > 22 > surprise Percent
-339.6937
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-04-30
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
1.2213
Earnings History > 23 > eps Estimate
1.68
Earnings History > 23 > eps Difference
-0.4587
Earnings History > 23 > surprise Percent
-27.3036
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2019-12-31
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
2.1178
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-09-30
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.9195
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-06-30
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
1.4722
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2019-03-31
Earnings History > 27 > report Date
2019-03-31
Earnings History > 27 > date
2019-03-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
1.5394
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-12-31
Earnings History > 28 > report Date
2018-12-31
Earnings History > 28 > date
2018-12-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
0.0023
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-09-30
Earnings History > 29 > report Date
2018-09-30
Earnings History > 29 > date
2018-09-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
1.6044
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2018-06-30
Earnings History > 30 > report Date
2018-06-30
Earnings History > 30 > date
2018-06-30
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
1.3891
Earnings History > 30 > eps Estimate
-
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2018-03-31
Earnings History > 31 > report Date
2018-03-31
Earnings History > 31 > date
2018-03-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
1.1652
Earnings History > 31 > eps Estimate
-
Earnings History > 31 > eps Difference
0
Earnings History > 31 > surprise Percent
-
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2023-06-30)
Health Score
* Institutions hold a combined 0.00% of the total shares of Gilead Sciences Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
1.88
Date
2025-09-30
EPS Actual
2.47
EPS Estimate
2.14
EPS Difference
0.33
Surprise Percent
15.4206%
(Last Updated 2023-06-30)
(Last Updated 2023-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2023-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2023-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.